Market Place
Sourcing Support
All News #Library
Biotech
Appili Therapeutics To Showcase At World Vaccine Congress
30 Mar 2026 //
GLOBENEWSWIRE
Appili Therapeutics Completes Second Tranche Of Private Placement
18 Feb 2026 //
GLOBENEWSWIRE
Appili Therapeutics Closes Initial Tranche Of Private Placement
18 Dec 2025 //
GLOBENEWSWIRE
Appili Therapeutics Plans Non-Brokered Private Placement
05 Nov 2025 //
GLOBENEWSWIRE
Appili Pharma, Vitalex Biosciences Secure $40M NIAID Contract
01 Oct 2025 //
GLOBENEWSWIRE
Appili Showcases Tularemia Vaccine Progress at NATO CBRN Event
09 Sep 2025 //
GLOBENEWSWIRE
Appili Therapeutics, Colleagues Show ATI-1701 Tularemia Vaccine
06 Aug 2025 //
GLOBENEWSWIRE
Appili President to Join Aditxt CEO for Weekly Update 4/4/25
02 Apr 2025 //
GLOBENEWSWIRE
Appili Provides Update On ATI-1701 Vaccine Candidate At IDWeek™
17 Oct 2024 //
GLOBENEWSWIRE
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc
02 Apr 2024 //
BUSINESSWIRE
Appili Announces Issuance of Patent for ATI-1701 Biodefense Vaccine Candidate
15 Dec 2023 //
BUSINESSWIRE
Appili’s Biodefense Vaccine Candidate ATI-1701 is Awarded Additional Funding
25 Oct 2023 //
BUSINESSWIRE
Appili Secures Contract for ATI-1701 Funding from the U.S. Air Force Academy
08 May 2023 //
BUSINESSWIRE
Biotech receives award from DOD; Regulators accept Appili Therapeutics` NDA
08 Feb 2023 //
ENDPTS
Appili Appoints Dr. Carl Gelhaus & Arthur Baran to support the ATI-1701 Program
17 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.